Login / Signup

Autophagy in hepatic fibrosis.

Yang SongYingying ZhaoFei WangLichan TaoJunjie XiaoChangqing Yang
Published in: BioMed research international (2014)
Hepatic fibrosis is a leading cause of morbidity and mortality worldwide. Hepatic fibrosis is usually associated with chronic liver diseases caused by infection, drugs, metabolic disorders, or autoimmune imbalances. Effective clinical therapies are still lacking. Autophagy is a cellular process that degrades damaged organelles or protein aggregation, which participates in many pathological processes including liver diseases. Autophagy participates in hepatic fibrosis by activating hepatic stellate cells and may participate as well through influencing other fibrogenic cells. Besides that, autophagy can induce some liver diseases to develop while it may play a protective role in hepatocellular abnormal aggregates related liver diseases and reduces fibrosis. With a better understanding of the potential effects of autophagy on hepatic fibrosis, targeting autophagy might be a novel therapeutic strategy for hepatic fibrosis in the near future.
Keyphrases
  • endoplasmic reticulum stress
  • cell death
  • induced apoptosis
  • signaling pathway
  • oxidative stress
  • cell cycle arrest
  • liver fibrosis
  • multiple sclerosis
  • drug delivery
  • current status
  • binding protein